Clinical trial

The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in…

NCT00145665 · Radboud University Medical Center, Other · Terminated

Key facts

NCT number NCT00145665
Title The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases
Official title The Role of 3-Deoxy-3[18]Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver Metastases
Lead sponsor Radboud University Medical Center, Other
Status Terminated
Phase Phase 1/Phase 2
Study type Interventional
Conditions Colorectal Neoplasms, Liver Neoplasms
Intervention type Procedure
Interventions FLT-PET scan
Enrollment 80
Start date Jan 1, 2005
Primary completion Dec 1, 2011
Completion Dec 1, 2012
First posted Sep 5, 2005
Last update posted Sep 5, 2011
Countries Netherlands

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies